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Abstract Background: While it is assumed that neuraxial
analgesia and pain management may beneficially influence
perioperative hemodynamics, few studies provided data quantifying such effects and none have assessed the potential
contribution of the addition of a nerve block. Questions/Purposes: This clinical trial compared the visual analog scale
(VAS) scores and measurement of arterial tone using augmentation index of patients who received combined spinal–epidural (CSE) only to patients who received both CSE and lumbar
Level of Evidence: Therapeutic study, level II.
Work performed at Hospital for Special Surgery.
Electronic supplementary material The online version of this article
(doi:10.1007/s11420 015 9477 1) contains supplementary material,
which is available to authorized users.

plexus block. Methods: After obtaining written consent, 92
patientsundergoingtotalhiparthroplastywererandomizedto
receiveeitherCSEorCSEwithlumbarplexusblock(LPB).
PerioperativepainandarterialtoneweremeasuredusingVAS
scores andaugmentationindex (AI)respectively, at baseline
andatvarioustimespostoperatively.Results:Aftertheexclusion of 2 patients, 44 patients received CSE alone and 46
patients received CSE and LPB. Patient demographics and
perioperative characteristics were similar in both groups. AI
continuously decreased after placement of a CSE with or
withoutLBP,beyondfullresolutionofneuraxialandperipheralblockade.AlthoughtheLPBgroupdemonstratedastatistically significant reduction of VAS pain scores in the
postanesthesiacareunit(PACU;P<0.05),overall,theaddition
ofaLPBdidnotsignificantlyreducetheAIwhencomparedto
thecontrolgroup.Conclusion:TheadditionofaLPBprovided
better pain control in the PACU but did not reduce the AI,
compared to the control group. We conclude that the addition
ofaLPBmayhavelimitedabilitytoaffectarterialtoneinthe
presence of a continuous infusion of epidural analgesics. In
summary, the addition of a LPB in patients undergoing total
hip arthroplasty is clinically effective and provided better pain
control, especially in the immediate postoperative period. The
continuous decrease on the AI in both groups beyond the full
resolutionoftheneuroaxialandLPBwillrequirefurtherstudies.
Introduction
Pain causes activation of the autonomic nervous system,
thus increasing vascular tone, which may potentially contribute to the risk of adverse perioperative cardiovascular
events [12, 13]. It has been well established that regional
anesthetictechniquesareeffectiveinreducingpostoperative
pain. As such, epidural coupled with or without peripheral

nerve blocks has been widely utilized to provide optimal
analgesia to patients [2, 20].
Although some authors suggest that this improved control of
pain relates to superior cardiovascular outcomes [4, 11], few
studies have actually provided data linking pain control to an
improved hemodynamic profile and none have measured the
effects on large vessel arterial tone, a major determinant of
cardiac afterload [25]. Optimizing perioperative hemodynamics
is of utmost importance in patients with limited cardiac reserve.
In this context, patients undergoing total hip arthroplasty represent an especially important target for intervention, as they frequently present with significant cardiovascular compromise [16].
In an attempt to maximize pain control, it has become
common practice at our institution to combine patientcontrolled epidural analgesia with a single-injection lumbar
plexus block (LPB) for patients undergoing total hip arthroplasty.
However, to date, it has been difficult and impractical to
measure the effect of regional analgesia on arterial vascular
tone. With the advent of new, non-invasive technology, we
were able to design a study to address this question. Arterial
tone or vascular stiffness can be measured with the
Pulsecor® monitor using a simple blood pressure cuff which
can measure changes in arterial pulse wave reflections. This
allows calculation of the augmentation index (AI) as a
measure of arterial tone [15, 17].
The goal of this study was to measure the effect of
combined spinal–epidural (CSE) anesthesia with or without
the addition of a LPB on arterial tone and pain. We hypothesized that (1) the use of regional anesthesia would decrease
the arterial tone compared to baseline, (2) the addition of a
LPB to CSE anesthesia alone would result in a further
decrease in vascular tone, and (3) the addition of LBP would
lead to superior pain control compared to CSE alone.
Patients and Methods
This randomized controlled clinical trial received approval
from the Institutional Review Board of Hospital for Special
Surgery (IRB #28098) [6]. Informed consent was obtained
from all individual participants included in the study. Using
Excel-based randomizing software, all treatment assignments were prepared prior to study commencement by unaffiliated research personnel. Randomized treatments were
placed in sealed opaque envelopes and were opened only
after the treating anesthesiologist obtained written informed
consent from the patient. After verifying the randomized
assignment, the treating anesthesiologist proceeded with
administration of the control (CSE alone) or treatment
(CSE with the addition of a LPB) anesthetic protocol. Study
patients and data assessors remained blinded throughout the
patients’ participation. Enrollment for primary outcome was
completed on January 14, 2011.
Patients scheduled for primary total hip arthroplasty
(THA) were eligible for participation if they were between
the ages of 60 and 100 and could safely undergo neuraxial
anesthesia and whose health status was rated as 1–3, as per the
American Society of Anesthesiologists (ASA) Physical Classification System [1]. Exclusion criteria were patient refusal,

patients not within IRB-approved age range, surgery other
than primary THR, chronic opioid use (defined as daily use
of opioids for more than 3 months), allergy to study medications, and contraindication to CSE anesthesia or LPB (history
of lumbar spinal fusion, bleeding disorder, use of clinically
relevant anticoagulant or antiplatelet medications, anatomic
abnormalities, infection at a potential injection site).
Intraoperatively, all patients received standard monitoring, a radial arterial line, oxygen via nasal cannula, and
sedation with 5 mg of intravenous midazolam. For CSE,
all patients received an intrathecal injection consisting of
60 mg of 1.5% mepivacaine [24]. A 20-gauge epidural
catheter was passed into the epidural space. Intraoperative
sedation was provided with intravenous propofol (2–4 mg
per kilogram body weight per hour), titrated to achieve
sedation while maintaining adequate ventilation. As needed,
the epidural was dosed with 2% lidocaine in 3-ml aliquots in
order to achieve hypotensive anesthesia at a target mean
arterial blood pressure of 55 mmHg [21]. During surgical
closure, 4 mg of intravenous ondansetron was administered.
For blinding purposes, control patients were prepared as
if they were receiving LPB, and a bandage was placed on the
patients’ backs in the appropriate site for LPB.
Ninety-two patients were enrolled after obtaining informed consent. Of those, 90 were included in the final data
analysis. Forty-six patients received a CSE (control), and 46
patients received both CSE and LPB (treatment). Two patients from the control group had to be excluded due to
equipment failure (see Fig. 1 for the CONSORT flow diagram). No adverse events attributable to either technique
occurred. There was no significant difference in patient
de mographics, ASA status, preopera tive use of
antiinflammatory medication, length of surgery, blood loss,
incidence of transfusion, or wound drainage (Table 1).
The management of patients in the treatment group differed
only in the addition of a LPB performed prior to the neuraxial
anesthetic, but after sedation as previously described [3]. After
sterile preparation and local anesthesia to the skin, a 21-gauge
Stimuplex needle (B. Braun, Bethlehem, PA) was inserted with
initial nerve stimulator settings of 2 mA and 2 Hz. After
obtaining quadriceps stimulation at less than 1.0 mA, 30 ml
of 0.5% bupivacaine was given in incremental doses of 5 ml.
Other than the study intervention (LPB), the postoperative analgesia regimen was identical for both groups. All
patients received epidural analgesia consisting of a combination of 0.06% bupivacaine and 10 μg/ml hydromorphone.
The patient-controlled epidural analgesia (PCEA) was
started immediately upon arrival in the recovery room. Patients received a continuous infusion of 2 ml/h, with an
additional bolus of 4 ml on demand and a lockout of
10 min with a 20 ml/h maximum. The epidural continuous
infusion was switched to demand dose (basal rate 0 ml/h) by
noon of postoperative day 1, the epidural catheter was removed at noon the same day.
Arterial tone was measured with the Pulsecor® monitor,
using a simple blood pressure cuff by assessing changes in
arterial pulse wave reflections as published previously [15,
17, 23]. The augmentation index (AI) was used as the
primary measure of arterial tone. A blinded research
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Fig. 2. The temporal development of augmentation index (AI) across
different time points. Baseline = holding area before OR; OR = in the
OR, before block placement; PACU 1 = in the PACU, after resolution
of residual motor blockade; PACU 2 = 2 h after PACU 1; POD 1 =
morning of postoperative day 1; POD 2 = morning of postoperative
day 2. CSE = control (combined spinal epidural anesthesia only),
CSE+LPB = treatment (combined spinal epidural anesthesia and lum
bar plexus block).

level of 0.1, we calculated that a sample size of 45 patients
per group will yield to 80% power.
Patient demographics and clinical outcomes are summarized with descriptive statistics. Results are expressed as the
median (interquartile range), mean ± standard deviation
(SD), or number (%) as appropriate and compared using
chi-square test for categorical and Mann–Whitney U test
for continuous variables. Independent two-group Mann–
Whitney U test was also performed to compare the mean
AI index for CSE and CSE+LPB groups at time point
PACU-1.
Secondary analyses included a longitudinal assessment
of VAS score differences over time and an analysis of trend
of AI over time. Normality of the data was assessed using
descriptive tools such as normality qq plots. Longitudinal
analysis of VAS score and AI changes over time was performed using linear mixed-effects regression modeling. In
each model, VAS or AI was the response variable with time
as the repeated effect and patient as a random effect. Missing
data was handled using multiple imputation. All P values
were two-sided with statistical significance evaluated at the
0.05 alpha level. All analyses were performed in R: A
Language and Environment for Statistical Computing, R
Development Core Team, Vienna, Austria, 2011.
Results

tympanic thermometer (Covidien, Mansfield, MA); a complete blood count was performed to determine potential
influencing variables (white blood cell count, hemoglobin
level, and hematocrit).
The primary outcome was the AI at PACU-1 in patients
who received lumbar plexus block with CSE, compared to
patients who received CSE alone. Secondary outcomes included changes of AI over time, as well as intergroup differences in pain scores, cumulative epidural medication,
opioid consumption, incidence of postoperative itching, nausea, antiemetic consumption, body temperature, white blood
cell count, hemoglobin, and hematocrit.
The sample size was computed to detect an effect size (a
difference in mean AI between the two groups) at PACU-1
of 30% with an estimated variability of 50. Using an alpha

No significant difference in AI as measured by the
Pulsecor® device became apparent between groups at time
point PACU-1 (CSE only, 1.13 (interquartile range 0.94);
CSE+LPB, 1.14 (interquartile range 0.93); P=0.778). In the
first linear mixed-effects regression model (longitudinal
analysis of AI), time was associated with a highly significant
impact as a repeated effect (P<0.0001), while the influence
of the group effect was not statistically significant
(P = 0.542). Please refer to Fig. 2 for a presentation of
temporal development of mean AI.
A longitudinal analysis of VAS indicates that the treatment group exhibited significantly lower pain scores compared to the control group, particularly at time point PACU1 (group effect, P=0.0077). Please refer to Table 2 for VAS
scores. Figure 3 displays model-adjusted mean VAS scores

Table 2 Total opioid consumption

Total morphine equivalent oral opioid use only (mg)
Total morphine equivalent PCA use only (mg)
Total morphine equivalent PCA and oral opioid use (mg)
Number of patients using antiemetics over 48 h following surgery
Number of patients using antipruitics over 48 h following surgery
Number of patients reporting nausea (POD 1)
Number of patients reporting nausea (POD 2)
Number of patients reporting itching (POD 1)
Number of patients reporting itching (POD 2)

Control (CSE only)

Treatment (CSE with LPB)

47±30
23±14
71±37
19 (43%)
10 (23%)
11 (25%)
7 (16%)
14 (32%)
5 (11%)

41±25
19±10
60±33
20 (43%)
15 (33%)
14 (30%)
7 (15%)
14 (30%)
5 (11%)

P value
0.251
0.113
0.150
0.977
0.295
0.565
0.928
0.887
0.941

Consumption of opioids, antiemetics, antipruritics, and incidence of nausea and itching among patients undergoing total hip arthroplasty by
groups. Data presented as mean±standard deviation. P values calculated using Mann Whitney U test (continuous variables) and chi square test
(categorical variables)
CE combined spinal epidural anesthesia, LPB lumbar plexus block

Fig. 3. Model adjusted visual analog scale (VAS) pain score means
for the two groups. CSE = combined spinal epidural anesthesia, LPB =
lumbar plexus block. Time points: PACU 1 = in the PACU, after
resolution of residual motor blockade; PACU 2 = 2 h after PACU 1;
POD 1 = morning of postoperative day 1; POD 2 = morning of
postoperative day 2.

for each of the two groups. There were no differences in total
opioid consumption (both oral and via PCA) calculated as
morphine equivalents, incidence of postoperative itching,
nausea, or requirement of antiemetic medication across
groups (Table 3). Moreover, the potential confounders (temperature, white blood cell count, hemoglobin, and hematocrit) are not statistically different.
Discussion
In this study, we compared combined spinal–epidural (CSE)
alone to CSE in conjunction with lumbar plexus block
(LPB) in patients undergoing total hip arthroplasty. The
specific aims were to assess whether (1) the use of regional
anesthesia would decrease the arterial tone compared to
baseline, (2) the addition of a LPB to neuraxial anesthesia

Table 3 Postoperative pain scores

PACU 1
PACU 2
Postoperative day 1
Postoperative day 2

Control
(CSE only,
N=44)

Treatment
(CSE with LPB,
N=46)

P value

2.75 (7.00)
2.00 (2.25)
1.00 (2.50)
2.50 (3.50)

0.00 (2.50)
1.25 (3.00)
1.00 (2.0)
1.50 (2.0)

0.0077

This table details postoperative visual analog scale (VAS) pain scores
at different time points. PACU 1 = PACU, after resolution of residual
motor blockade; PACU 2 = 2 h after PACU 1; POD 1 = morning of
postoperative day 1; POD 2 = morning of postoperative day 2. VAS
scores are presented as median (interquartile range). P value calculated
using linear mixed effects regression modeling

alone would result in a further decrease in vascular tone, and
(3) the addition of LBP would lead to superior pain control
compared to LPB alone.
Our study is limited by a number of factors. First, we
applied continuous epidural infusion in both groups, which
represents standard of care at the study institution. Yet this
may be the reason for reduced differences in AI found
between groups by overriding the effects of the LPB on
arterial tone. Presumably, a more pronounced difference
would become apparent when comparing patients with
neuraxial anesthesia to those receiving general anesthesia,
respectively. Second, as pain scores were not our primary
outcome, VAS sampling was not carried out at time points
prior to surgery. Therefore, no assertions about comparative
preoperative and postoperative pain scores can be made.
However, as participants were randomly assigned to either
treatment or control group, and as no differences in their
demographics or surgical parameters become apparent, existence of a significant sampling bias is unlikely.
We found a significant postoperative drop in the vascular
tone (AI) compared to the preoperative baseline reading.
The decreasing trend lasted well beyond resolution of
neuraxial and peripheral nerve blockade. Looking at the
temporal development of AI in our sample, after an initial
slight increase, a continuous decline can be observed starting
at the first postoperative measurement, when the motor
blockade had already worn off. This development may in
part be attributable to a decrease in vascular tone triggered
by neuraxial and/or regional anesthesia. Decrease in sympathetic outflow (through concomitant blockade of ganglia and
nerves of the autonomic nervous system) is a well-studied
effect of regional anesthetic techniques. This partial sympathectomy and subsequent vasodilatation was observed in
spinal and epidural analgesia as well as after performance
of peripheral nerve blocks; yet, whether there is an influence
of different local anesthetic agents and concentrations is not
fully understood [5, 8, 22].
Interestingly, AI reached its peak in the operating room,
shortly before the procedure started, and it kept decreasing
steadily until the last day of sampling on postoperative day
two (POD-2), even after the neuraxial analgesia and the
peripheral nerve block (in the intervention group) had worn
off. This finding indicates postoperative changes in vascular tone outlasting the direct effects of sympathetic blockade and possibly prevailing for a much longer time than
previously anticipated. Jans et al. recently found a high
incidence of symptomatic postoperative orthostatic intolerance after fast-track total hip arthroplasty under spinal
anesthesia, at 6 and 24 h postoperatively [10]. The authors
controlled for a number of factors, possibly causing the
observed poor cardiovascular response to orthostatic challenge during mobilization, among them hypovolemia, anemia, opioid administration, postoperative pain, and residual
spinal blockade. However, none of these findings seems to
sufficiently explain the frequent occurrence of orthostatic
intolerance. Consequently, other factors might exist that
exert significant influence on the reactivity of the vascular
system, and subsequently on AI and orthostatic intolerance.
On the one hand, surgery-related metabolic injury and

increased postoperative discharge of pro-inflammatory cytokines are known to cause short-term reductions in arterial
tone through immune-system-related mechanisms [18, 19].
On the other hand, psychological stress and anxiety preceding surgery follows a similarly decreasing pattern in
most patients. Indeed, a study by Logan et al. linked
increased psychological stress to increased arterial stiffness,
measured using carotid–femoral pulse wave velocity sampling [14]. Although this study was not carried out in
surgical patients, similar occurrences in a perioperative
setting seem intuitive.
However, no further reduction of AI became apparent in
those patients receiving a lumbar plexus block in addition to
the neuraxial anesthesia. The resulting effect of the lumbar
plexus block had a non-significant impact on the AI. This
non-significant comparative intergroup difference in AI we
observed in our sample can likely be attributed to the pronounced effect of neuraxial analgesia alone on arterial tone,
overriding the impact of the LPB to a certain degree.
Furthermore, LPB did significantly reduce the pain
scores in the recovery room compared to controls. Patients
receiving a LPB in addition to CSE had lower pain levels
when compared to controls, particularly in the early postoperative phase, when there is no other form af analgesia but
the LPB. In the late postoperative phase, other forms of
analgesia are administered. These results are consistent with
numerous recent publications demonstrating the significance
of peripheral regional anesthesia in total hip arthroplasty [7,
9]. Moreover, LPB can be a valuable additional approach to
analgesia in patients where neuraxial anesthesia is
contraindicated.
There is a theoretical increase on the fall rate on the
patients with LP; this can be avoided with a careful assessment of the strength by the physical therapist before each
session. In fact, we did not have any falls during the study.
In summary, the addition of a LPB in patients undergoing total hip arthroplasty provided better pain control, especially in the immediate postoperative period. However, the
highly significant decline of AI affected both groups equally.
Given the known sympatholytic effects of regional anesthesia, further research could focus on the comparative impact
of general anesthesia or intravenous analgesia versus regional anesthesia on AI to identify potential benefits of the latter.
Furthermore, as AI continued to decrease after the sympathetic blockade had resolved and probably even further
beyond our last measurement, research into other factors
potentially influencing vascular reactivity could serve to
clarify mechanisms involved in the development of postoperative dizziness and other symptoms of orthostatic
intolerance.
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